96 related articles for article (PubMed ID: 18042666)
1. Connexin-32 acts as a downregulator of growth of thyroid gland.
Prost G; Bernier-Valentin F; Munari-Silem Y; Selmi-Ruby S; Rousset B
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E291-9. PubMed ID: 18042666
[TBL] [Abstract][Full Text] [Related]
2. Impact of connexin32 deletion on E7 or RET/PTC3 oncogene-driven growth and neoplastic transformation of the thyroid gland.
Prost G; Bernier-Valentin F; Croset M; Rousset B
Endocr Relat Cancer; 2009 Sep; 16(3):873-84. PubMed ID: 19509066
[TBL] [Abstract][Full Text] [Related]
3. Protective role of connexin 32 in steady-state hematopoiesis, regeneration state, and leukemogenesis.
Hirabayashi Y; Yoon BI; Tsuboi I; Huo Y; Kodama Y; Kanno J; Ott T; Trosko JE; Inoue T
Exp Biol Med (Maywood); 2007 May; 232(5):700-12. PubMed ID: 17463168
[TBL] [Abstract][Full Text] [Related]
4. Differential control of connexin-32 and connexin-43 expression in thyroid epithelial cells: evidence for a direct relationship between connexin-32 expression and histiotypic morphogenesis.
Munari-Silem Y; Guerrier A; Fromaget C; Rabilloud R; Gros D; Rousset B
Endocrinology; 1994 Aug; 135(2):724-34. PubMed ID: 8033821
[TBL] [Abstract][Full Text] [Related]
5. Cx32 formation and/or Cx32-mediated intercellular communication induces expression and function of tight junctions in hepatocytic cell line.
Kojima T; Spray DC; Kokai Y; Chiba H; Mochizuki Y; Sawada N
Exp Cell Res; 2002 May; 276(1):40-51. PubMed ID: 11978007
[TBL] [Abstract][Full Text] [Related]
6. Connexin 32 fused to the green fluorescent protein retains its ability to control the proliferation of thyroid cells.
Flachon V; Durand C; Selmi-Ruby S; Rousset B; Munari-Silem Y
Cell Commun Adhes; 2001; 8(4-6):447-52. PubMed ID: 12064633
[TBL] [Abstract][Full Text] [Related]
7. Formation of three-dimensional thyroid follicle-like structures by polarized FRT cells made communication competent by transfection and stable expression of the connexin-32 gene.
Tonoli H; Flachon V; Audebet C; Callé A; Jarry-Guichard T; Statuto M; Rousset B; Munari-Silem Y
Endocrinology; 2000 Apr; 141(4):1403-13. PubMed ID: 10746644
[TBL] [Abstract][Full Text] [Related]
8. Thyroid cell proliferation in response to forced expression of gap junction proteins.
Flachon V; Tonoli H; Selmi-Ruby S; Durand C; Rabilloud R; Rousset B; Munari-Silem Y
Eur J Cell Biol; 2002 May; 81(5):243-52. PubMed ID: 12067060
[TBL] [Abstract][Full Text] [Related]
9. Disruption of neuromedin B receptor gene results in dysregulation of the pituitary-thyroid axis.
Oliveira KJ; Ortiga-Carvalho TM; Cabanelas A; Veiga MA; Aoki K; Ohki-Hamazaki H; Wada K; Wada E; Pazos-Moura CC
J Mol Endocrinol; 2006 Feb; 36(1):73-80. PubMed ID: 16461928
[TBL] [Abstract][Full Text] [Related]
10. Endotoxin unmasks the role of gap junctions in the liver.
Correa PR; Guerra MT; Leite MF; Spray DC; Nathanson MH
Biochem Biophys Res Commun; 2004 Sep; 322(3):718-26. PubMed ID: 15336523
[TBL] [Abstract][Full Text] [Related]
11. Gap junction expression and cell proliferation in differentiating cultures of Cx43 KO mouse hepatocytes.
Kojima T; Fort A; Tao M; Yamamoto M; Spray DC
Am J Physiol Gastrointest Liver Physiol; 2001 Oct; 281(4):G1004-13. PubMed ID: 11557521
[TBL] [Abstract][Full Text] [Related]
12. Endogenous thyrocyte-produced nitric oxide inhibits iodide uptake and thyroid-specific gene expression in FRTL-5 thyroid cells.
Fozzatti L; Vélez ML; Lucero AM; Nicola JP; Mascanfroni ID; Macció DR; Pellizas CG; Roth GA; Masini-Repiso AM
J Endocrinol; 2007 Mar; 192(3):627-37. PubMed ID: 17332530
[TBL] [Abstract][Full Text] [Related]
13. Negative growth control of renal cell carcinoma cell by connexin 32: possible involvement of Her-2.
Fujimoto E; Satoh H; Negishi E; Ueno K; Nagashima Y; Hagiwara K; Yamasaki H; Yano T
Mol Carcinog; 2004 Jul; 40(3):135-42. PubMed ID: 15224345
[TBL] [Abstract][Full Text] [Related]
14. Replacement of connexin 43 by connexin 32 in a knock-in mice model attenuates aortic endothelium-derived hyperpolarizing factor-mediated relaxation.
López D; Rodríguez-Sinovas A; Agulló E; García A; Sánchez JA; García-Dorado D
Exp Physiol; 2009 Oct; 94(10):1088-97. PubMed ID: 19617266
[TBL] [Abstract][Full Text] [Related]
15. WY-14,643-mediated promotion of hepatocarcinogenesis in connexin32-wild-type and connexin32-null mice.
Moennikes O; Stahl S; Bannasch P; Buchmann A; Schwarz M
Carcinogenesis; 2003 Sep; 24(9):1561-5. PubMed ID: 12819187
[TBL] [Abstract][Full Text] [Related]
16. A spontaneously arising mutation in connexin32 with repeated passage of FRTL-5 cells coincides with increased growth rate and reduced thyroxine release.
Green LM; Murray DK; Tran DT; Nelson GA; Shah MM; Luben RA
J Mol Endocrinol; 2001 Oct; 27(2):145-63. PubMed ID: 11564600
[TBL] [Abstract][Full Text] [Related]
17. Delayed liver regeneration and increased susceptibility to chemical hepatocarcinogenesis in transgenic mice expressing a dominant-negative mutant of connexin32 only in the liver.
Dagli ML; Yamasaki H; Krutovskikh V; Omori Y
Carcinogenesis; 2004 Apr; 25(4):483-92. PubMed ID: 14688024
[TBL] [Abstract][Full Text] [Related]
18. Lack of phenobarbital-mediated promotion of hepatocarcinogenesis in connexin32-null mice.
Moennikes O; Buchmann A; Romualdi A; Ott T; Werringloer J; Willecke K; Schwarz M
Cancer Res; 2000 Sep; 60(18):5087-91. PubMed ID: 11016633
[TBL] [Abstract][Full Text] [Related]
19. Connexin 32 gap junctions enhance stimulation of glucose output by glucagon and noradrenaline in mouse liver.
Stümpel F; Ott T; Willecke K; Jungermann K
Hepatology; 1998 Dec; 28(6):1616-20. PubMed ID: 9828226
[TBL] [Abstract][Full Text] [Related]
20. Connexin32 is expressed in vascular endothelial cells and participates in gap-junction intercellular communication.
Okamoto T; Akiyama M; Takeda M; Gabazza EC; Hayashi T; Suzuki K
Biochem Biophys Res Commun; 2009 May; 382(2):264-8. PubMed ID: 19265674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
